Clinical Trial Update: Occipital Nerve Stimulation (ONS) for Migraine: OPTIMISE [NA]

View source ↗

Summary

Clinical trial update for occipital nerve stimulation (ONS) in migraine (OPTIMISE) has been terminated; results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine Disorders

Drugs mentioned

• Occipital nerve stimulation

Snippet

Sponsor: Boston Scientific Corporation | Conditions: Migraine Disorders | NA | Status: TERMINATED | Results posted: 2018-11-02